Laborate Pharmaceuticals India Ltd.

Size: px
Start display at page:

Download "Laborate Pharmaceuticals India Ltd."

Transcription

1 Laborate Pharmaceuticals India Ltd. About us: LABORATE is one of the fastest growing pharmaceutical company in India, since 1985 as manufacturers and exporters of pharmaceutical formulation. We are privileged to have been partners, physicians and chemist's trusted aide for over 29 years. Mission: Bring values to life with Quality Care Products at Affordable Price. To provide total customer satisfaction with speedy delivers at competitive prices with confidence of trust by maintain long term health relationship. Vision: To be a leading Generic Global Company in World Awards & Rewards: Laborate is honored with EMERGING INDIAN AWARD by ICICI and CNBC, 2008 UDYOG RATTAN AWARD EXCELLENCE AWARD by Institute of Economic Studies (IES), 2008 Achievements & Milestones: In 2007, IMS ORG ranked Laborate Pharmaceuticals amongst the top 50 pharmaceutical companies in India. Laborate Pharmaceuticals has crossed USD 100 Mn mark in year , with export turnover of around USD 20 Mn. Manufacturing Facilities: We have three world class, State of the art manufacturing facilities approved by WHO GMP. These facilities are made as per the guidelines of US FDA and UK MHRA. Our multiple dosage form plants can manufacture several products at time and capable of handling high pressure, high temperature to low temperature (from 25 o C to 7 o C).

2 Locations: (1) Plant I: E 11, Industrial Area, Panipat, Haryana, India Dosage forms: Tablet; Capsules; Dry & Liqud Injectables; E/E Drops; Topical Preparations (2) Plant II: 51, Industrial Area, Paonta Sahib, Dist. Sirmour (H.P.) India Dosage forms: Tablet; Capsules; Dry & Liqud Injectables; E/E Drops; Topical Preparations (3) Plant III: 31, Rajban Road, Nariwala, Paonta Sahib, Dist. Sirmour (H.P) India, Dosage forms: Tablet; Capsules; Dry & Liqud Injectables; E/E Drops; Topical Preparations; Dry & Liquid Orals. Accreditation: We have WHO GMP certificated manufacturing Plants. Our world class, state of the art manufacturing facilities are approved by FDA of 15 countries. FDA Approvals: NAFDAC Nigeria Pharmacy and Poison Board Kenya MOH Yemen MOH Tajikistan MOH Bhutan CDDRA, Sri Lanka MOH Iraq FDB Ghana MOH Sierra Leone CAMEG, Togo CAMEBU, Burundi CAMERWA, Rwanda Government of India recognized Export House

3 Our Presences: In Indian Market: Laborate Pharmaceuticals India Ltd a leading name in Indian Pharmaceutical sector manufacturing a wide range of dosages form operates four successful divisions in domestic market. The Health Care, Life Science, Multicure and Zypher are four marketing division reaching different customer segments with an aim for achieving better coverage, customer satisfaction & cost effectiveness. These divisions ensure right quality of product available at the right price at right time. Laborate is having highly skilled field force of 300 people which makes our presence across all 35 states of India. We have strong distribution network through our 3 Depo, 8 C&F agents, 118 Distributors and 5072 Stockist. In International Market: Since 1989, Laborate has been exporting its products to Europe, U.K, South Africa, and Eastern Western African countries under its brand name with our products registered in more than 35 countries. We have established an international marketing network by virtue of quality our products, which are marketed worldwide. We have separate team for regulatory affairs who constantly work on preparations of all documents like products registration dossiers, stability testing, bioavailability and COPP of all drugs. The export division monitors the growing need of our customers worldwide & caters to their specific demands with efficiency and effectiveness. It is this philosophy which forms the backbone of our export division. We always focused our strategy towards doing things on time, to be able to adapt to customer's requirements and doing things in a cost effective manner. Our Products are registered in following countries: Asian Countries - Middle East Countries - Caribbean Countries - Sri Lanka Myanmar Afghanistan Nepal Thailand Bhutan Philippines Iraq Yemen Jordan Lebanon Syria West Indies Trinidad & Tobago Guatemala Costa Rica African Countries European Countries - CIS Countries - Nigeria Sierra Leone Burkina Faso Ghana Kenya Uganda Tanzania Benin Mozambique Guinée Burundi Rwanda Togo Ivory Coast Angola Mauritius Madagascar Liberia England Germany Netherlands Belgium Italy CHMP France Tajikistan Turkménistan Uzbekistan

4 Our Partners: International Partners: Laborate is having Marketing License Agreement with Leading Pharmaceutical Companies for Nigeria and Sri Lanka. We are one of the Preferred Supplier Status for World s Leading Institutions and Government Health Ministries. We are also the approved supplier to World Health Organization (WHO) Our products are procured across the world by some of the leading Ministry of Health & Health care organization like: CHMP France IMRES Netherlands Embassy pharma Nigeria CAMEC Burkina Faso SPC Sri Lanka MOH Mauritius CAMERWA Rwanda PNA Senegal CAMEBU Burundi FDA Nepal CAMEG Togo PSI Ivory Coast MOH Thailand PPB Kenya Quality Aspect: Quality control and quality assurance is an independent department which follows strict guidelines of quality control, quality assurance and in process control test. The testing of raw, packaging and finished materials is done by highly qualified technical staff with full specification and complete testing facilities.

5 Our all equipments operated under PLC (Programmable Logic Controller). We have in house quality checks, which are detailed in our SOP s and properly documented. Our State of the art in house testing facilities equipped with GC, FTIR, HPLC, UV and other latest techniques complying with International Pharmacopeial requirements. Quality Policy: We ensure that all recommendations of national and international regulations and guidelines are implemented timely and effectively practiced. It is our endeavor to bring delight to our internal and external customers through excellence and continuous improvement. Production Capacity: Laborate Pharmaceuticals offers sterile and non sterile products. We are engaged in the manufacturing of sterile injectables (Lyophilized & Non Lyophilized Injections). We can manufacture high value low volume to high volume finished formulations. We have exclusives dedicated blocks for β lactum and non β lactum antibiotics. Our current production on daily basis is about Liquid injections 200,000 vials & 300,000 ampoules. Ophthalmic 300,000 Dry Injections 300,000 Topical Preparations 200,000 tubes Tablets 15 Mn units Capsules 2 Mn units Dry Syp 100, 000 Bottles Liquid Preparations 100,000 (Syp/ Emulsions/ Susp) Product Range: We are amongst the few pharmaceutical companies in India which is having huge basket of finished formulations. Laborate is having 300+ products in its product portfolio which includes Antibiotics, Antifungal, Antipyretic, Anti inflammatory, Analgesics, (Steroids and NSAID s drugs), Antiulcerants, Multivitamins, Calcium and Iron supplements, Eye and Ear Drops, Cough and Cold remedies, Anti Asthmatic and Anti Histaminic, Dermatology, Cardio Diabetic, Gynecologist, ENT,

6 Ophthalmic Products. We also have products for Erectile Dysfunction, OTC, Neutracueticals and Ayurvedic Preparations. Our dosage form includes: Injectable: β Lactum and Non β Lactum Injectables Lyophilized (Dry) & Non Lyophilized (Liquid) Injections Infusions (100ml) Large Volume Parenterals Tablets: : β Lactum and Non β Lactum Capsules: : β Lactum and Non β Lactum Syrups and Suspensions: β Lactum and Non β Lactum Liquid Syrups and Suspension Dry Syrup Paediatric Drops Ophthalmic & ENT drops Topical Preparations Derma Range (Anti Acne / Antibiotics / Antifungal /Antiviral / Analgesics / Topical Steroids / Cosmetic Products) Topical Preparations for Erectile Dysfunction

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook UNICEF Supply Division Update: October 2013 0 Pneumococcal Conjugate Vaccine (PCV) Supply & Demand Outlook October 2013 Update Key updates

More information

67 Years of Leadership in Pharmacy. A Journey of Continuous Improvement

67 Years of Leadership in Pharmacy. A Journey of Continuous Improvement 67 Years of Leadership in Pharmacy A Journey of Continuous Improvement September 2012 GALENIKA A.D. IS The only Serbian state-owned pharmaceutical company Manufacturer of generic drugs its manufacturing

More information

300 3PORTUGUESE 65M GLOBAL WHO WE ARE WE OFFER PORTUGUESE

300 3PORTUGUESE 65M GLOBAL WHO WE ARE WE OFFER PORTUGUESE WHO WE ARE PORTUGUESE WE OFFER Licensing out Contract Manufacturing Packaging Services EU Batch Release R&D Services Marketing & Distribution Medinfar is a fully integrated Pharmaceutical Company with

More information

Eligibility List 2018

Eligibility List 2018 The Global Fund s 2017-2022 strategy and allocation-based approach enables strategic investment to accelerate the end of HIV/AIDS, tuberculosis and malaria and build resilient and sustainable systems for

More information

Annex 2 A. Regional profile: West Africa

Annex 2 A. Regional profile: West Africa Annex 2 A. Regional profile: West Africa 355 million people at risk for malaria in 215 297 million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 233 million to US$ 262

More information

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP) COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP) Sushila Maharjan Senior Manager, Innovative Finance International Conference on Sustainable Cooling World Bank Washington DC - 29 November 2018 Reach

More information

High-Quality Delivery On Short Time Best Prices

High-Quality Delivery On Short Time Best Prices High-Quality Delivery On Short Time Best Prices Establishment Establishment - 1975. The leading Toothbrush / Oral Care manufacturing company in Africa and The Middle East since 1980 s. Total workforce

More information

Update on progress of MPP sublicensees

Update on progress of MPP sublicensees Update on progress of MPP sublicensees Medicines Patent Pool SEPTEMBER 2018 SUMMARY This presentation showcases the progress made by MPP licensees (generic pharmaceutical companies) To date, MPP has signed

More information

INDO-AFRICA PHARMA BUSINESS MEET

INDO-AFRICA PHARMA BUSINESS MEET INDO-AFRICA PHARMA BUSINESS MEET AYUSH Exports & Potentials by: Ranjit Puranik, Chief Executive Officer, Shree Dhootapapeshwar Limited Overall Exports from ASU&H Industry Economic region wise Export Analysis

More information

THE CARE WE PROMISE FACTS AND FIGURES 2017

THE CARE WE PROMISE FACTS AND FIGURES 2017 THE CARE WE PROMISE FACTS AND FIGURES 2017 2 SOS CHILDREN S VILLAGES INTERNATIONAL WHERE WE WORK Facts and Figures 2017 205 58 79 families and transit 31 Foster homes 162 8 3 173 214 2 115 159 136 148

More information

about us Cyndea Pharma independent

about us Cyndea Pharma independent 2014 02 about us Cyndea Pharma is an independent Spanish laboratory specialized in the development and manufacturing of generic formulations all of which is done in the latest state-of-the-art high containment

More information

What is this document and who is it for?

What is this document and who is it for? Measles and Rubella Initiative s Standard Operating Procedures for Accessing Support for Measles and Rubella Supplementary Immunization Activities During 2016 In the context of measles and rubella elimination

More information

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2 Current State of Global HIV Care Continua Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2 1) International Association of Providers of AIDS Care

More information

NO CHILD SHOULD DIE OF DIABETES

NO CHILD SHOULD DIE OF DIABETES NO CHILD SHOULD DIE OF DIABETES THE PROBLEM There is an estimated 1 million youth under the age of 25 with diabetes in the world. In high income countries, children with diabetes have full access to the

More information

Prioritizing Emergency Polio Eradication Activities

Prioritizing Emergency Polio Eradication Activities Prioritizing Emergency Polio Eradication Activities Managing the Financing Gap the other half of the Emergency Hamid Jafari GPEI Financing 2012-13: Budget = $2.23 b - Confirmed contributions = $1.14 b

More information

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division Rotavirus Vaccine: & Demand Update UNICEF Division July 0 Rotavirus Vaccine (RV): & Demand Update July This update provides new information on countries and their scheduled RV introductions, forecasted

More information

Aboubacar Kampo Chief of Health UNICEF Nigeria

Aboubacar Kampo Chief of Health UNICEF Nigeria Aboubacar Kampo Chief of Health UNICEF Nigeria Many thanks to UNICEF colleagues in Supply Division-Copenhagen and NY for contributing to this presentation Thirty-five countries are responsible for 98%

More information

Impact Dashboard - October 2014

Impact Dashboard - October 2014 Impact Dashboard - 2014 By 2014, PSI and its network members averted an estimated 44.2 million DALYs globally. PSI has met 60.6% of the strategic plan (SP) target to avert 198.7 million DALYs, and 56.4%

More information

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia Funding for AIDS: The World Bank s Role Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia Outline New resources needs estimates Bridging the gap Global overview of

More information

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

CONTRACEPTIVE SOCIAL MARKETING STATISTICS 2016 CONTRACEPTIVE SOCIAL MARKETING STATISTICS August 2017 CONNECT WITH US Courtesy of DKT International 1701 K Street, NW Suite 900 Washington DC 20006 SOCIAL MARKETING STATISTICS 2016 Highlights 2016

More information

Impact Dashboard - August 2014

Impact Dashboard - August 2014 Impact Dashboard - By, PSI and its network members averted an estimated 29.7 million DALYs globally. PSI has met 53.3% of the strategic plan (SP) target to avert 198.7 million DALYs, and 53.0% of the SP

More information

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i Sourcing of ARVs & HIV diagnostics Procurement for Impact P4i AMDS ANNUAL STAKEHOLDERS AND PARTNERS MEETING 29 September 2014 Global Fund: Procurement for Impact: P4i Our objective was straightforward:

More information

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ ) 1 / 11 Region/Subregion/ Country Africa Eastern Africa Kenya Madagascar Mauritius Uganda United Republic of Tanzania Northern Africa Algeria Egypt Libya Morocco Sudan Southern Africa Botswana Burkina Faso

More information

Procedure for Expedited Review of imported pre-qualified vaccines for use in national immunization programmes

Procedure for Expedited Review of imported pre-qualified vaccines for use in national immunization programmes Procedure for Expedited Review of imported pre-qualified vaccines for use in national immunization programmes Dr Nora Dellepiane/Dr Anil Kumar Chawla WHO/HQ-Geneva, Switzerland 1 Expedited review procedure

More information

Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality

Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality Washington DC March 12th 2008 Professor Wendy J Graham Opinion-based decisionmaking Evidence-based decision-making

More information

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

CONTRACEPTIVE SOCIAL MARKETING STATISTICS 2017 CONTRACEPTIVE SOCIAL MARKETING STATISTICS September 2018 CONNECT WITH US Courtesy of DKT International 1701 K Street, NW Suite 900 Washington DC 20006 SOCIAL MARKETING STATISTICS 2017 Highlights 2017

More information

Comparative Analyses of Adolescent Nutrition Indicators

Comparative Analyses of Adolescent Nutrition Indicators Comparative Analyses of Adolescent Nutrition Indicators Rukundo K. Benedict, PhD The DHS Program Stakeholders Consultation on Adolescent Girls Nutrition: Evidence, Guidance, and Gaps October 30 31, 2017

More information

Sino implant (II) Increasing Access by Introducing a Low Cost Contraceptive Implant

Sino implant (II) Increasing Access by Introducing a Low Cost Contraceptive Implant Sino implant (II) Increasing Access by Introducing a Low Cost Contraceptive Implant Markus J. Steiner, Diane Luo, Aida M. Cancel, David Jenkins, David Asante, Heather Vahdat, Haizhen Meng ICFP: Research

More information

Global Fund Results Fact Sheet Mid-2011

Global Fund Results Fact Sheet Mid-2011 Global Fund Results Fact Sheet Mid-2011 This fact sheet outlines some of the common questions and answers regarding results reported by Global Fund-supported programs, including the principles and approach

More information

TT Procured by UNICEF

TT Procured by UNICEF TT TT Procured by UNICEF 2001-08 250,000,000 200,000,000 150,000,000 100,000,000 50,000,000 0 2001 2002 2003 2004 2005 2006 2007 2008 Routine SIA TT historical demand and forecast overview Upcoming Tender

More information

O c t o b e r 1 0,

O c t o b e r 1 0, STUDENT VOICES FROM THE FIELD: WORLD HEALTH ORGANIZATION GENEVA, SWITZERLAND O c t o b e r 1 0, 2 0 1 6 M o l l y P e z z u l o University at Albany School of Public Health MPH Epidemiology Candidate 17

More information

MATERNAL, NEWBORN, AND CHILD HEALTH

MATERNAL, NEWBORN, AND CHILD HEALTH MATERNAL, NEWBORN, AND CHILD HEALTH SESSION OBJECTIVES Introduction to GHSC-PSM Maternal, Newborn, and Child Health (MNCH) strategy and priorities Defining MNCH commodities Overview of historical and current

More information

Why is Medicine Quality Important?

Why is Medicine Quality Important? Why is Medicine Quality Important? March 3, 2015 Boston University School of Public Health Pharmaceutical Track Spring Symposium Laura Krech, MPH Consultant, based in Boston Promoting the Quality of Medicines

More information

מדינת ישראל. Tourist Visa Table

מדינת ישראל. Tourist Visa Table Updated 23/05/2017 מדינת ישראל Tourist Visa Table Tourist visa exemption is applied to national and official passports only, and not to other travel documents. Exe = exempted Req = required Press the first

More information

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

CONTRACEPTIVE SOCIAL MARKETING STATISTICS 2016 CONTRACEPTIVE SOCIAL MARKETING STATISTICS August 2017 CONNECT WITH US Courtesy of DKT International 1701 K Street, NW Suite 900 Washington DC 20006 SOCIAL MARKETING STATISTICS 2016 Highlights 2016

More information

US Imports of Essential Oils, 2009 to 2013 Part One

US Imports of Essential Oils, 2009 to 2013 Part One US Imports of Essential Oils, 2009 to 2013 Part One Import volumes and unit values for a range of essential oil imports into the US are given in the Tables below. Data for a further range of oils will

More information

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT UNICEF / Zar Mon Annexes EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT This report includes nine nutrition statistics, as per the 2017 Global Nutrition Report. These

More information

PHARMA LIMITED (NIGERIA)

PHARMA LIMITED (NIGERIA) FROM DIRECTORS DESK At Savocent we believe that "Quality is not an act but it is a habit." Savocent is dedicated to meet the needs of customers through discovering, developing, manufacturing & marketing

More information

AIDS in Africa. An Update. Basil Reekie

AIDS in Africa. An Update. Basil Reekie AIDS in Africa An Update Basil Reekie Contents General Statistics The trend of HIV in Africa Ugandan experience UNAIDS 2006 Latest African Statistics by Country HIV Intervention Light at the end of the

More information

Seizures of ATS (excluding ecstasy ), 2010

Seizures of ATS (excluding ecstasy ), 2010 Seizures of ATS (excluding ecstasy ), 2010 (countries and territories reporting seizures* of more than 10 kg) 9 5.1 8.7 12.9 Ghana Armenia 0.7 9.9 1 2.1 Syrian Arab Republic Korea (Republic of) Iraq Islamic

More information

impact dashboard - august 2018

impact dashboard - august 2018 impact dashboard - august 2018 PSI 2015 As of August, PSI averted an estimated 15.2 M DALYs, provided 10.9 M CYPs, and reached 16.7 M users globally. Globally PSI has reached at least 16.7 million users

More information

Providing affordable and innovative medicines for healthier lives. Q1 FY2016 Earnings Presentation August 2015

Providing affordable and innovative medicines for healthier lives. Q1 FY2016 Earnings Presentation August 2015 Providing affordable and innovative medicines for healthier lives Q1 FY2016 Earnings Presentation August 2015 Highlights of the Quarter Q1 FY2016 vs. Q1 FY2015 Management Perspective o Net Revenue of Rs.

More information

Tipping the dependency

Tipping the dependency BREAKING NEWS Meeting the investment challenge Tipping the dependency balance Domestic investments exceed international investments total reaching US$ 8.6 billion. 40 countries fund more than 70% of their

More information

impact dashboard - june 2018

impact dashboard - june 2018 impact dashboard - june 2018 As of June, PSI averted an estimated 11.3 M DALYs, provided 8.1 M CYPs, and reached 12.5 M users globally. Ethiopia, Zambia, and Cameroon have made considerable progress on

More information

Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions

Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions Core competencies in primary care: Supplement 2 Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions The Core competencies in

More information

Market Updates: Routine Vaccine Introductions IPV. Vaccine Industry Consultation October 2018 UNICEF Supply Division

Market Updates: Routine Vaccine Introductions IPV. Vaccine Industry Consultation October 2018 UNICEF Supply Division Market Updates: Routine Vaccine Introductions IPV Vaccine Industry Consultation October 2018 UNICEF Supply Division Outline Review of rapid introduction of IPV Overview of the current situation for 2018

More information

2015 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

2015 CONTRACEPTIVE SOCIAL MARKETING STATISTICS 2015 CONTRACEPTIVE SOCIAL MARKETING STATISTICS November 2016 CONNECT WITH US Courtesy of DKT International 1701 K Street, NW Suite 900 Washington, DC 20006 1 SOCIAL MARKETING STATISTICS 2015 Highlights

More information

Pharmacovigilance BMGF Perspective. Raj Long Bill & Melinda Gates Foundation

Pharmacovigilance BMGF Perspective. Raj Long Bill & Melinda Gates Foundation Pharmacovigilance BMGF Perspective Raj Long Bill & Melinda Gates Foundation Overview 1. Key challenges -Recap Safety Surveillance Working Group (2012/2013) 2. Overall BMGF strategy and approach 3. Key

More information

February Health Impact Report 2010

February Health Impact Report 2010 February Health Impact Report 1,391,742 Feb'10 DALYs: 7.5% of strategic target goal is 14% 26% decrease from Feb'09 Feb' 10 DALYs include: :: 1,350,675 product s :: 41,067 BCC DALYs todate in 9 countries:

More information

Worldwide Regulatory Perspective on Herbal Drugs & Herbal formulations

Worldwide Regulatory Perspective on Herbal Drugs & Herbal formulations Dr.Mohan Krishna.,M.Pharm.,Ph.D professor Krishna Teja Pharmacy College Tirupathi Worldwide Regulatory Perspective on Herbal Drugs & Herbal formulations 2 Terminology Herbal Substances are mainly whole,

More information

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents. Updated 25/05/2015 ישראל Tourist Visa Table Tourist visa exemption is applied to national and official passports only, and not to other travel documents. (C) Bearers of official passports requiring tourist

More information

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved UNAIDS / JC2225E The designations employed and the presentation of the material in this publication

More information

Global Fund ARV Fact Sheet 1 st June, 2009

Global Fund ARV Fact Sheet 1 st June, 2009 Global Fund ARV Fact Sheet 1 st June, 2009 This fact sheet outlines the principles and approach in determining the number of people on antiretroviral drugs (ARVs) for HIV/AIDS treatment, with a breakdown

More information

impact dashboard - september 2018

impact dashboard - september 2018 impact dashboard - september 2018 PSI 2015 As of, PSI averted an estimated 17.1 M DALYs, provided 12.5 M CYPs, and reached 18.4 M users globally. Globally PSI has reached at least 18.4 million users across

More information

impact dashboard - may 2018

impact dashboard - may 2018 impact dashboard - may 2018 As of May, PSI averted an estimated 8.0 M DALYs, provided 6.2 M CYPs, and reached 8.1 M users globally. In May alone, PSI added 2.6 M users toward the goal of 90 M reached by

More information

CND UNGASS FOLLOW UP

CND UNGASS FOLLOW UP CND UNGASS FOLLOW UP INCB follow-up activities on Chapter 2. Operational recommendations on ensuring the availability of and access to controlled substances exclusively for medical and scientific purposes,

More information

Various interventions for controlling sexually transmitted infections have proven effective, including the syndromic

Various interventions for controlling sexually transmitted infections have proven effective, including the syndromic levels, as understaffing is a chronic issue in all the countries that are scaling up male circumcision. Current achievements notwithstanding, it is necessary to reinforce and strengthen national political

More information

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000)

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000) Recent trends in malnutrition in developing regions 109 Annex 1 Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, ) The tables in this Annex

More information

ANNEX 3: Country progress indicators

ANNEX 3: Country progress indicators : progress indicators 541 : COUNTRY PROGRESS INDICATORS 2006 REPORT ON THE GLOBAL AIDS EPIDEMIC Annex 3 : COUNTRY PROGRESS INDICATORS As of March 2006, 115 countries had reported indicators on progress

More information

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 2011 APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS (SEE TABLE 4.9) Africa The Americas South-East Asia Europe Eastern Mediterranean Western Pacific

More information

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS 29 June 2009 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, 31 August 4 September 2009 Provisional agenda item 9.2 PROGRESS REPORT ON CHILD SURVIVAL: A

More information

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA 5 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 17.1 PROGRESS REPORT ON THE ROAD MAP FOR

More information

ICM: Trade-offs in the fight against HIV/AIDS

ICM: Trade-offs in the fight against HIV/AIDS ICM: Trade-offs in the fight against HIV/AIDS 1 As the HIV/AIDS pandemic enters its 25 th year, both the number of infections and number of deaths due to the disease continue to rise. Despite an enormous

More information

UNAIDS Office on AIDS, Security and Humanitarian Response; Initiative on HIV/AIDS and Uniformed Services, with special emphasis on young recruits

UNAIDS Office on AIDS, Security and Humanitarian Response; Initiative on HIV/AIDS and Uniformed Services, with special emphasis on young recruits REGIONS COUNTRY PROJECT DESCRIPTION MONITORING / South and South East Cambodia Bangladesh UNAIDS to support HIV/AIDS prevention activities for Demobilizing personnel UNAIDS to support HIV/AIDS prevention

More information

EFFERVESCENT in the 21st century

EFFERVESCENT in the 21st century DORTMUND LABORATORIES PVT. LTD. De ning EFFERVESCENT in the 21st century Defining EFFERVESCENT in the 21st Century QUALITY CONTROL The Company maintains WHO GMP Standards. Safety and Environmental Preservation

More information

Global reductions in measles mortality and the risk of measles resurgence

Global reductions in measles mortality and the risk of measles resurgence Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there

More information

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI ( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI Long partnership between; IRRI & PhilRice IRRI & JICA PhilRice & JICA The Season Long

More information

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts (charts in colour) (These charts will be updated in 2014) 2 1. Introduction 2. Instructions on how to use

More information

impact dashboard year-end with 2017 coefficients

impact dashboard year-end with 2017 coefficients impact dashboard - 2017 year-end with 2017 coefficients In 2017, PSI averted an estimated 30.5 million DALYs and provided 20 million CYPs globally. PSI met global 2017 program targets for DALYs averted

More information

October 2011 Monthly Health Impact Report

October 2011 Monthly Health Impact Report HEALTH IMPACT REPORT October Monthly Health Impact Report OCTOBER, PSI AVERTED AN ESTIMATED 17,899,945 DALYs (88% of the strategic target, the goal is 80%). This is a 66% increase from. Oct. 11 DALYs averted

More information

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF), Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF), 2008-2010 Claudio Politi and Oumar Sagna Department of Immunization Vaccines and Biologicals, World Health

More information

Disparities in access: renewed focus on the underserved. Rick Johnston, WHO UNC Water and Health, Chapel Hill 13 October, 2014

Disparities in access: renewed focus on the underserved. Rick Johnston, WHO UNC Water and Health, Chapel Hill 13 October, 2014 Disparities in access: renewed focus on the underserved Rick Johnston, WHO UNC Water and Health, Chapel Hill 13 October, 2014 Sector proposal for post-2015 targets By 2030: to eliminate open defecation;

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Pronyk PM, Nemser B, Maliqi B, et al, for the

More information

#TEAM45. Fundraising Guide

#TEAM45. Fundraising Guide #TEAM45 Fundraising Guide Action Against Hunger USA One Whitehall Street, 2nd Floor New York, NY 10004 212.967.7800 info@actionagainsthunger.org www.actionagainsthunger.org WELCOME TO #TEAM45! Thank you

More information

Financing malaria control

Financing malaria control Chapter 6. Financing malaria control The three major sources of funds for malaria control pro - grammes are national government spending, external assistance from donors and household or private out-of-pocket

More information

Medicines Regulation, Regulatory Harmonization, Global Initiatives. Tonya Villafana, PhD, MPH Senior Health Specialist, World Bank

Medicines Regulation, Regulatory Harmonization, Global Initiatives. Tonya Villafana, PhD, MPH Senior Health Specialist, World Bank Medicines Regulation, Regulatory Harmonization, Global Initiatives Tonya Villafana, PhD, MPH Senior Health Specialist, World Bank September, 13, 2012 Presentation Outline The importance of regulation Attributes

More information

Prohibition of importation, manufacturing and sale of Smokeless Tobacco products.

Prohibition of importation, manufacturing and sale of Smokeless Tobacco products. Prohibition of importation, manufacturing and sale of Smokeless Tobacco products www.untobaccocontrol.org/kh/smokeless-tobacco/ BACKGROUND. Over the past decade, the WHO FCTC has served as a powerful tool

More information

We are a WHO GMP & ISO 9001:2000 certified company engaged in the Manufacturing and Exporting of Pharmaceutical Formulations. We are committed to

We are a WHO GMP & ISO 9001:2000 certified company engaged in the Manufacturing and Exporting of Pharmaceutical Formulations. We are committed to We are a WHO GMP & ISO 9001:2000 certified company engaged in the Manufacturing and Exporting of Pharmaceutical Formulations. We are committed to providing the best quality products at highly competitive

More information

Why Invest in Nutrition?

Why Invest in Nutrition? Why Invest in Nutrition? Meera Shekar Human Development Network World Bank 2006 Three key Issues Why reducing malnutrition is essential to poverty reduction? Is malnutrition a BIG problem? How can we improve

More information

Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa

Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa Measurement/indicators of youth employment Gora Mboup Global Urban Observatory (GUO) UN-HABITAT

More information

Expert Group Meeting on the Regional Report for the African Gender and Development Index

Expert Group Meeting on the Regional Report for the African Gender and Development Index Expert Group Meeting on the Regional Report for the African Gender and Development Index 9-10 October 2017 United Nations Conference Centre, Addis Ababa, Ethiopia Aide Memoire July 2017 I. Background and

More information

Global Fund Mid-2013 Results

Global Fund Mid-2013 Results Global Fund Mid-2013 Results This fact sheet outlines some of the common questions and answers regarding results reported by Global Fund-supported programs, including the principles and approach in determining

More information

UNAIDS 2013 AIDS by the numbers

UNAIDS 2013 AIDS by the numbers UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since

More information

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report

Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report Foot-and-Mouth Disease Situation Food and Agriculture Organization of the United Nations Monthly Report October 2013 I N F O R M A T I O N S O U R C E S U S E D: Databases: OIE WAHID World Animal Health

More information

Vaccine Banks. Susanne Munstermann, OIE Scientific and Technical Department

Vaccine Banks. Susanne Munstermann, OIE Scientific and Technical Department Vaccine Banks Susanne Munstermann, OIE Scientific and Technical Department Rift Valley fever: New Options for Trade, Prevention and Control Djibouti, 21 23 April 2015 Establishing a Regional Vaccine Bank

More information

Maternal, Newborn and Child Health: Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York

Maternal, Newborn and Child Health: Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York Maternal, Newborn and Child Health: Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York Copenhagen, Denmark 23 September 2013 Visit www.everywomaneverychild.org

More information

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority HIBA ABDALRAHIM Capsca Focal Point Public Health Authority Introduction Definition Symptom Transmission Global situation Local situation Control Content Introduction Yellow fever (YF) is a mosquito-borne

More information

What is Treatment Optimisation (TO)

What is Treatment Optimisation (TO) Outline What is treatmen optimisation Why is treatment optimisation important for the future of HIV treatment and care Drugs optimisation Some strategies for moving the TO agend forward Discussion: Why

More information

What is the recent experience of programs that distribute contraceptives free of charge versus for a price?

What is the recent experience of programs that distribute contraceptives free of charge versus for a price? What is the recent experience of programs that distribute contraceptives free of charge versus for a price? A Review of the Literature Jane T. Bertrand and Rebecca Emel 8 October 2015 @rhsupplies @rh_supplies

More information

Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative

Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative 28 October 2008 Geneva 1 CHAI Work in Diagnostics - Context Diagnostic Test Agreements - In 2002 when CHAI was formed, the price of many

More information

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12 5 August 9 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, August 4 September 9 POLIOMYELITIS ERADICATION: PROGRESS REPORT Information Document CONTENTS

More information

HPV Vaccine Lessons Learned & New Ways Forward

HPV Vaccine Lessons Learned & New Ways Forward HPV Vaccine Lessons Learned & New Ways Forward The Gavi Alliance June 2016, Geneva www.gavi.org Overview 1 Background 2 Lessons learned 3 New Way Forward 2 1 Background 3 HPV Background HPV is responsible

More information

Maternal Deaths Disproportionately High in Developing Countries

Maternal Deaths Disproportionately High in Developing Countries EMBARGOED until Monday, 20 October, 6am GMT HQ/2003/24 20 October 2003 CF/DOC/PR/2003-82 Maternal Deaths Disproportionately High in Developing Countries African women are 175 times more likely to die in

More information

JOINT TB AND HIV PROGRAMMING

JOINT TB AND HIV PROGRAMMING JOINT TB AND HIV PROGRAMMING Haileyesus Getahun, WHO. On behalf of the Global Fund Interagency TB and HIV Working Group (Global Fund, PEPFAR, Stop TB Partnership, UNAIDS, WHO) I was admitted in a hospital

More information

Post-2015 Development Agenda THE WORLD WE WANT

Post-2015 Development Agenda THE WORLD WE WANT Post-2015 Development Agenda THE WORLD WE WANT Brian Lutz United Nations Development Programme United Nations Development Programme OVERVIEW The MDGs, Health and HIV Post-2015 processes and results to-date

More information

PROGRESS REPORT ON DECADE OF TRADITIONAL MEDICINE IN THE AFRICAN REGION. Progress Report. CONTENTS Paragraphs BACKGROUND PROGRESS MADE...

PROGRESS REPORT ON DECADE OF TRADITIONAL MEDICINE IN THE AFRICAN REGION. Progress Report. CONTENTS Paragraphs BACKGROUND PROGRESS MADE... 5 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 17.2 PROGRESS REPORT ON DECADE OF TRADITIONAL

More information

COMPANY PROFILE. AL SHAMS Group

COMPANY PROFILE. AL SHAMS Group COMPANY PROFILE AL SHAMS Group Al Shams Pharma Scintific Bureau Shams Al-Ibdaa Drug Store Bilim Pharma Co. Al-Shams Drug Store Al-Murjan Drug Store Al-Aqsa Pharmacy & Cosmetic Al-Khadraa Pharmacy & Cosmetic

More information

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers! 1. HOME PAGE Welcome to our world of Dry Powder Inhalers! Andi-Ventis Ltd, established in 2001 is a joint venture between Medochemie Ltd, Cyprus and Miat SpA Italy, founded to carry out the pharmaceutical

More information